Excel Industries reported Q1 FY27 revenue of ₹294 Cr, a ~5% dip YoY, primarily due to weak demand for Agrochemical Intermediates amidst erratic monsoons.

However, strong performance from other product groups and new contract manufacturing projects helped cushion the impact.

The company is strategically diversifying into specialty chemicals, completing a dedicated facility for a 5-year supply agreement (annual revenue potential ₹35-40 Cr). Another new specialty chemical facility (₹5 Cr capex) is slated for a Feb 2027 launch.

Future growth includes ₹200-300 Cr capex over three years for plant upgrades & expansion, plus solar energy initiatives.

Product launches in Biocides and Performance Solutions are on track for FY27. EBITDA remained stable at ₹42 Cr, boosting margins to 14.4%. PAT dipped 13.3% YoY to ₹29 Cr, largely due to lower non-operating income.

Management foresees continued challenges in Agrochemicals but expects non-agrochemical segments and the new dedicated facility to drive performance.

They remain agile amid raw material volatility.